Loading...
Droplette
A breakthrough skincare device, clinically proven to be up to 90% more effective than traditional skincare
Overview
Date Established | 10/2017 |
Founder | Madhavi Gavini |
Headquarters | Boston, MA |
Industries |
Beauty
Tech
|
Website | https://droplette.io/ |
Press Contact | Caroline Chau, Jack Taylor PR |
Social |
|
About
Droplette is pioneering future-focused skincare through its patented breakthrough technology. Initially developed as a medical device, Droplette’s Micro-Infuser employs a contactless solution to deliver skincare ingredients 20 times deeper into the skin than topical application, where they are 90% more effective.
Designed for use with capsules containing clinical-strength, dermatologist-approved formulations, users can easily customize their treatments to achieve targeted results at home without needles or other invasive methods.
Female-founded by MIT-trained PhD scientists, Droplette is funded by NASA, the National Institutes of Health, and Walter Reed Army Institute of Research, and an honoree of the 2021 Fast Company’s World Changing Ideas, among other notable awards.
Founding Story
Droplette was initially developed by MIT-trained PhD scientists, Madhavi Gavini (CEO) and Rathi Srinivas (CTO), to serve as a transdermal delivery system for a debilitating skin disease called Epidermolysis Bullosa (EB). Following countless prototypes and experiments, they recognized they had discovered a fluid physics phenomena that could be applied to dramatically enhance your everyday skincare routine.
With funding from NASA, the National Institutes of Health, and Walter Reed Army Institute of Research, Madhavi created Droplette and it’s signature device, the Micro-Infuser, which employs a contactless solution to deliver skincare ingredients 20 times deeper into the skin than topical application where they are 90% more effective. Designed for use with capsules containing clinical-strength, dermatologist-approved formulations.
Products

Sign In to Continue
×You must be signed in as a media user to and interact with hundreds of media-ready brands.
Create your Media account
×
Sign In to Continue
×You must be signed in as a media user to and interact with hundreds of media-ready brands.
Create your Media account
×
Sign In to Continue
×You must be signed in as a media user to and interact with hundreds of media-ready brands.
Create your Media account
×
Sign In to Continue
×You must be signed in as a media user to and interact with hundreds of media-ready brands.
Create your Media account
×
Sign In to Continue
×You must be signed in as a media user to and interact with hundreds of media-ready brands.
Create your Media account
×
Sign In to Continue
×You must be signed in as a media user to and interact with hundreds of media-ready brands.
Create your Media account
×
Sign In to Continue
×You must be signed in as a media user to and interact with hundreds of media-ready brands.
Create your Media account
×Team Bios

Madhavi Gavini
Co-Founder and CEO
Madhavi Gavini is the founder & CEO at Droplette. She is a mathematician by training with degrees from MIT & Johns Hopkins. Prior to founding/inventing Droplette, she developed drug design algorithms using protein structure prediction models based on algebraic topology and invented a class of peptide drugs that were granted the first FDA orphan disease designation for Pediatric Cardiomyopathy since 1994. More recently, one of the molecules she developed was used by Sandia National Labs as an experimental therapeutic for Covid-associated cardiac and pulmonary damage. Her work has been featured by the American Heart Association and published in both textbooks and journals including Frontiers and she has co-authored two book chapters.
Affiliates
Press
Press Releases
Gallery
Loading Related Guides...
Sign In to Continue
×You must be signed in as a media user to from Droplette and interact with hundreds of other media-ready brands.